Details for Patent: 8,616,196
✉ Email this page to a colleague
Which drugs does patent 8,616,196 protect, and when does it expire?
Patent 8,616,196 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-five patent family members in twenty-two countries.
Summary for Patent: 8,616,196
| Title: | Inhalation device and a method for assembling said inhalation device |
| Abstract: | An inhalation device for delivering doses of medicament to a user comprising: --a canister (5), said canister being adapted to accommodate the medicament to be dispensed to a user, and --a counter (15) which is connected to the canister (5). According to the invention --the canister (5) is adapted to receive the counter (15) on a base end (6a), --the counter and/or the canister further having contact parts (18, 20) for their attachment having means for increasing the friction and thereby allowing the counter to fixedly be attached onto the canister in a range of different positions in the lengthwise direction, --the counter further being adapted to during the process to assemble the counter to the canister, be urged onto the canister until the length of the counter and canister together is within a predefined tolerance of a predefined length. |
| Inventor(s): | Hodson; Darren (Leicestershire, GB), Treneman; William (Cambridgeshire, GB) |
| Assignee: | AstraZeneca AB (Sodertaije, SE) |
| Application Number: | 11/571,389 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; Use; |
Drugs Protected by US Patent 8,616,196
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,616,196
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 0401773 | Jul 2, 2004 |
| PCT Information | |||
| PCT Filed | June 23, 2005 | PCT Application Number: | PCT/SE2005/000994 |
| PCT Publication Date: | January 12, 2006 | PCT Publication Number: | WO2006/004496 |
International Family Members for US Patent 8,616,196
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 054294 | ⤷ Try a Trial | |||
| Austria | E499132 | ⤷ Try a Trial | |||
| Australia | 2005260193 | ⤷ Try a Trial | |||
| Brazil | PI0512848 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
